GTP-gamma S;
agonist efficacy;
genotype;
signal transduction;
D O I:
10.1016/S0361-9230(03)00014-5
中图分类号:
Q189 [神经科学];
学科分类号:
071006 ;
摘要:
Strain and sex differences in mu opioid-mediated antinociception have been reported in rodents. The present studies evaluated mu opioid receptor-mediated G-protein activation in Lewis and Fischer 344 (F344) male and female rats using agonist-stimulated [35]GTPgammaS binding. Compared to Lewis rats. F344 rats exhibited a 35% higher level of net DAMGO-stimulated [S-35]GTPgammaS binding in striatum. Basal [S-35]GTPgammaS binding was similar to30% lower in thalamus of Lewis than F344 rats. Female Lewis rats also exhibited slightly (similar to15%) lower basal [S-35]GTPgammaS binding in cingulate cortex relative to F344 rats of either sex. The relative efficacies of the mu partial agonists, morphine and buprenorphine, were also examined. Buprenorphine exhibited similar to40% lower relative efficacy in the periaqueductal gray in Lewis compared to F344 rats, but no other relative efficacy differences were found between strains or sexes. Moreover, regional differences in the relative efficacy of buprenorphine were also detected in Lewis but not F344 rats. In contrast to these results, the only difference found between sexes was the 13% lower basal [S-35]GTPgammaS binding in the cingulate cortex of female compared to male Lewis rats. These results suggest that differences in mu opioid receptor-mediated G-protein activation may contribute to strain differences in opioid antinociception, whereas sex differences may result predominantly from other mechanisms. (C) 2003 Elsevier Science Inc. All rights reserved.